Noile-Immune Biotech Inc.

TSE:4893 Stock Report

Market Cap: JP¥6.4b

Noile-Immune Biotech Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 4893?
Owner TypeNumber of SharesOwnership Percentage
Institutions1,497,2003.46%
Private Companies2,137,1204.94%
General Public7,406,77017.1%
Public Companies10,397,62524%
Individual Insiders21,863,05050.5%

Dilution of Shares: 4893 only recently listed within the past 12 months


Top Shareholders

Top 15 shareholders own 82.9% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
24%
Hiroko Ogihara
10,405,050JP¥1.5b-4.29%no data
18.8%
Takeda Pharmaceutical Company Limited
8,119,800JP¥1.2b0%no data
8.66%
Koji Tamada
3,750,000JP¥551.3m0%no data
5.26%
BINEX Co., Ltd.
2,277,825JP¥334.8m0%no data
4.62%
Kyoko Seto
2,000,000JP¥294.0m0%no data
4.62%
Hidenobu Ishizaki
2,000,000JP¥294.0m0%no data
4.55%
Satoshi Wada
1,970,000JP¥289.6m0%no data
3.15%
Yukimi Sakota
1,363,000JP¥200.4m0%no data
3.12%
DCI Partners Co., Ltd.
1,349,200JP¥198.3m0%8.55%
2.78%
Apricot Co., Ltd.
1,203,850JP¥177.0m0%no data
2.16%
BIGEN Co., Ltd.
933,270JP¥137.2m0%no data
0.81%
Hironari Hashioka
350,000JP¥51.4m0%no data
0.3%
Waverton Investment Management Limited
131,400JP¥19.3m0%no data
0.058%
Tsutomu Tokashiki
25,000JP¥3.7m0%no data
0.038%
York Capital Management
16,600JP¥2.4m0%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.